PRAXIS PRECISION MEDICINES, INC. Debt Securities, Available-for-sale, Unrealized Loss Position
PRAXIS PRECISION MEDICINES, INC. (PRAX) had Debt Securities, Available-for-sale, Unrealized Loss Position of $793.80 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $793.80M.
- 2026-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $763.20M.
- 2025-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $16.10M.
- 2025-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $72.00M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2026-06-30 | $793.80M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $763.20M 10-Q · filed 2026-05-07 |
| 2025-09-30 | $16.10M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $72.00M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $19.40M 10-Q · filed 2025-05-02 |
| 2024-09-30 | $8.00M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $227.00M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $42.60M 10-Q · filed 2024-05-13 |
| 2023-06-30 | $38.90M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $5.00M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $38.90M 10-Q · filed 2023-11-07 |
| 2022-09-30 | $48.30M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $76.40M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $90.80M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $95.80M 10-Q · filed 2022-11-09 |
| 2021-09-30 | $87.50M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $73.80M 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |